ALBEMARLE CORP quarterly report, Q3 FY2010

Albemarle Corporation — Q3 2010 Form 10-Q Summary

Business context and reporting period

Albemarle is a global specialty chemicals producer operating through Polymer Solutions, Catalysts, and Fine Chemistry. This unaudited Form 10-Q covers the three and nine months ended September 30, 2010, compared with the corresponding 2009 periods.

Financial performance and key metrics

MetricQ3 2010Q3 2009Change
Net sales$585.0 million$515.3 million+14%
Gross profit$196.8 million$134.1 million+47%
Gross margin33.6%26.0%+760 bps
Operating profit$120.6 million$62.9 million+92%
Operating margin20.6%12.2%+840 bps
Net income attributable to Albemarle$93.7 million$52.1 million+80%
Diluted EPS$1.02$0.57+79%
MetricNine months 2010Nine months 2009Change
Net sales$1.758 billion$1.447 billion+21%
Gross profit$549.5 million$334.4 million+64%
Gross margin31.3%23.1%+820 bps
Operating profit$303.5 million$122.8 million+147%
Operating margin17.3%8.5%+880 bps
Net income attributable to Albemarle$238.7 million$116.0 million+106%
Diluted EPS$2.59$1.26+106%

Q3 sales growth reflected a 12% volume benefit and 4% favorable price/mix, partly offset by a 2% foreign-exchange headwind. Management attributed margin expansion primarily to stronger volumes, pricing and mix, higher production rates, favorable fixed-cost absorption, and improved metals-cost pass-through in hydroprocessing catalysts.

  • Q3 segment sales were $231.8 million for Polymer Solutions, $214.8 million for Catalysts, and $138.4 million for Fine Chemistry.
  • Q3 segment income increased 125% for Polymer Solutions, 106% for Catalysts, and 16% for Fine Chemistry.
  • Equity income from unconsolidated investments rose to $9.2 million in Q3 and $30.0 million for the nine-month period.
  • Cash provided by operating activities was $275.7 million for the first nine months, compared with $259.4 million in 2009.
  • Capital expenditures were $50.0 million; net cash used in investing activities was $60.6 million.
  • Cash and cash equivalents increased to $424.7 million at September 30, 2010, from $308.8 million at December 31, 2009.
  • Total debt was $765.7 million, including $755.6 million classified as long-term debt, compared with $812.7 million at December 31, 2009.
  • The company reported $347.0 million of additional borrowing capacity under its revolving credit facility and $151.0 million under other existing lines, subject to covenants.
  • Cash dividends declared increased to $0.14 per share in Q3 from $0.125 per share in the prior-year quarter. A fourth-quarter dividend of $0.14 per share was declared on October 15, 2010.

Material changes versus the prior comparable period

  • All three segments benefited from improved demand and higher volumes following weak 2009 market conditions.
  • Polymer Solutions benefited from stronger consumer electronics, automotive, and construction demand, especially for brominated flame retardants.
  • Catalysts benefited from higher refinery and polyolefin catalyst volumes, favorable product mix, and improved metals-cost recovery.
  • Fine Chemistry benefited from higher performance chemicals and custom-manufacturing volumes, partly offset by unfavorable price/mix and foreign exchange.
  • Q3 2010 contained no restructuring or Port de Bouc charges. The first nine months included $7.0 million of restructuring charges related principally to planned workforce reductions at Bergheim, Germany. The comparable 2009 period included $12.4 million of Port de Bouc divestiture-related charges.
  • Effective January 1, 2010, Albemarle deconsolidated Stannica LLC after reducing its ownership to 50%; the retained investment is reported within unconsolidated investments.
  • Albemarle sold its Teesport, UK manufacturing site for approximately $8.6 million and began acquiring property and equipment in Yeosu, South Korea.

Guidance, outlook, risks, and unusual items

Management expected a moderate seasonal downturn entering the fourth quarter but anticipated ending 2010 with strong earnings. It expected the fundamentals supporting 2010 performance to support solid earnings growth in 2011. Management projected a 2010 effective tax rate of approximately 24.3% and 2010 capital expenditures of approximately $80 million to $90 million.

  • Yeosu, South Korea investments are intended to support metallocene polyolefin catalysts and trimethyl gallium markets. Intermediate commercial operations were expected in mid-2011, with full operation targeted for 2012.
  • Rare-earth material costs in the FCC catalysts business increased following Chinese export quotas; management cited supply-security measures and cost-pass-through mechanisms.
  • Recorded environmental liabilities were $14.2 million. Management estimated additional environmental remediation exposure could be up to approximately $17 million before tax, although timing and ultimate costs remain uncertain.
  • The company continued discussions with the EPA regarding alleged regulatory violations at its Orangeburg, South Carolina facility. Potential fines, penalties, or capital expenditures cannot be predicted with certainty.
  • Variable-rate borrowings totaled $397.0 million, or 52% of total debt. A hypothetical 10% rate change was estimated to affect annualized interest expense by approximately $0.5 million.
  • Foreign-currency forwards had a $323 million aggregate notional value and a $3.8 million net fair-value asset at September 30, 2010.
  • Key risks include economic conditions, customer demand and orders, raw-material and energy costs, foreign exchange, regulation, litigation, environmental obligations, pension costs, interest rates, financing-market conditions, and execution of cost-reduction and growth initiatives.

Most important facts for investors to verify

  • Whether volume growth, pricing, and favorable fixed-cost absorption remain sustainable after the expected seasonal fourth-quarter slowdown.
  • The extent to which metals-cost and rare-earth cost pass-through mechanisms protect Catalysts margins.
  • Progress, capital requirements, and customer qualification timing for the Yeosu, South Korea projects and the Saudi Arabia joint venture.
  • Debt maturities, revolving-credit availability, covenant compliance, and exposure to variable interest rates.
  • Potential cash costs from the Bergheim restructuring, environmental remediation, EPA proceedings, pensions, and uncertain tax positions.
  • The effect of the Stannica deconsolidation and other joint-venture changes on reported sales, earnings, cash flow, and noncontrolling interests.